Zdrowie i gospodarka · 18/07/2019
FDA Releases Draft Guidance for Developing Gonadotropin-Releasing Hormone Analogues for Advanced Prostate Cancer
The Food and Drug Administration (FDA) has released a draft guidance for the pharmaceutical industry on developing gonadotropin-releasing hormone analogues to treat advanced prostate cancer, as recommended by the FDA.